127 related articles for article (PubMed ID: 31348079)
1. Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT Scans.
Dhiantravan N; Hovey E; Bosco A; Wegner EA
Clin Nucl Med; 2019 Oct; 44(10):797-798. PubMed ID: 31348079
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY
Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322
[TBL] [Abstract][Full Text] [Related]
4. Follicular Lymphoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT.
Kanthan GL; Coyle L; Kneebone A; Schembri GP; Hsiao E
Clin Nucl Med; 2016 Jun; 41(6):500-1. PubMed ID: 26914565
[TBL] [Abstract][Full Text] [Related]
5. 18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer.
Meijer D; Wondergem M; Knol RJJ; Broos WAM; van der Zant FM
Clin Nucl Med; 2020 Feb; 45(2):e96-e97. PubMed ID: 31361646
[TBL] [Abstract][Full Text] [Related]
6. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
Rowe SP; Gorin MA; Hammers HJ; Som Javadi M; Hawasli H; Szabo Z; Cho SY; Pomper MG; Allaf ME
Ann Nucl Med; 2015 Dec; 29(10):877-82. PubMed ID: 26286635
[TBL] [Abstract][Full Text] [Related]
7. Intraindividual Comparison of
Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M
J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569
[TBL] [Abstract][Full Text] [Related]
8. Repeatability of Quantitative
Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE
J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729
[TBL] [Abstract][Full Text] [Related]
9. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
How Kit N; Dugué AE; Sevin E; Allouache N; Lesaunier F; Joly F; Aide N
Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435
[TBL] [Abstract][Full Text] [Related]
10. Effective Prostate-Specific Membrane Antigen-Based 18F-DCFPyL-Guided Cryoablation of a Single Positive Site in a Patient Believed to Be More Metastatic on 11C-Choline PET/CT.
Cornelis FH; Durack JC; Morris MJ; Scher HI; Solomon SB
Clin Nucl Med; 2017 Dec; 42(12):e516-e518. PubMed ID: 29099733
[TBL] [Abstract][Full Text] [Related]
11. Metastasized 18F-DCFPyL-Negative Prostatic Adenocarcinoma Without Neuroendocrine Differentiation.
Broos WAM; Kocken M; van der Zant FM; Knol RJJ; Wondergem M
Clin Nucl Med; 2018 Feb; 43(2):120-122. PubMed ID: 29261618
[TBL] [Abstract][Full Text] [Related]
12. Flourodeoxyglucose positron emission tomography scan may be helpful in the case of ductal variant prostate cancer when prostate specific membrane antigen ligand positron emission tomography scan is negative.
McEwan LM; Wong D; Yaxley J
J Med Imaging Radiat Oncol; 2017 Aug; 61(4):503-505. PubMed ID: 28349676
[TBL] [Abstract][Full Text] [Related]
13. Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT.
Zukotynski KA; Jadvar H; Potvin K; Cho SY; Kim CK; Winquist E
Clin Nucl Med; 2020 Sep; 45(9):727-729. PubMed ID: 32520499
[TBL] [Abstract][Full Text] [Related]
14. Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for
Jansen BHE; Jansen RW; Wondergem M; Srbljin S; de Klerk JMH; Lissenberg-Witte BI; Vis AN; van Moorselaar RJA; Boellaard R; Hoekstra OS; Oprea-Lager DE
J Nucl Med; 2020 Feb; 61(2):210-216. PubMed ID: 31481580
[TBL] [Abstract][Full Text] [Related]
15. 18F-DCFPyL PET/CT in a Single Large Metastasis With Prostate-Specific Antigen Level of 856 ng/mL.
Wondergem M; Srbljin S; van der Zant FM; Broos WAM; Knol RJJ
Clin Nucl Med; 2019 Oct; 44(10):e588-e589. PubMed ID: 31274553
[TBL] [Abstract][Full Text] [Related]
16. Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted
Meyer AR; Carducci MA; Denmeade SR; Markowski MC; Pomper MG; Pierorazio PM; Allaf ME; Rowe SP; Gorin MA
Ann Nucl Med; 2019 Aug; 33(8):617-623. PubMed ID: 31147927
[TBL] [Abstract][Full Text] [Related]
17. Positive Multifocal PSMA PET/CT in a Patient With Prostate Cancer and Follicular Lymphoma.
Dendl K; Merkel A; Kratochwil C; Choyke PL; Kleist C; Cardinale J; Haberkorn U; Giesel FL
Clin Nucl Med; 2022 Jan; 47(1):e47-e48. PubMed ID: 34319949
[TBL] [Abstract][Full Text] [Related]
18.
Wondergem M; van der Zant FM; Knol RJJ; Lazarenko SV; Pruim J; de Jong IJ
J Nucl Med; 2017 Nov; 58(11):1797-1804. PubMed ID: 28450569
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Discordant Lesions on Dual-Tracer PET/CT (
Chalikandy A; Yadav S; Basu S
J Nucl Med Technol; 2023 Dec; 51(4):339-342. PubMed ID: 37586854
[TBL] [Abstract][Full Text] [Related]
20. Hibernoma as an incidental finding on (18)F-FDG-PET/CT in lymphoma patient follow-up.
Navarro-Pelayo MM; Rodríguez-Fernández A; Ramírez-Navarro Á; Martín-Castro A; Gómez-Río M; Llamas-Elvira JM
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):53-5. PubMed ID: 25982593
[No Abstract] [Full Text] [Related]
[Next] [New Search]
